CAR T‐cell therapy for multiple myeloma: a clinical practice‐oriented review
NL Sadek, BA Costa, K Nath… - Clinical Pharmacology …, 2023 - Wiley Online Library
The emergence of chimeric antigen receptor (CAR) T‐cell therapy has revolutionized the
treatment of hematologic malignancies, including multiple myeloma (MM). Two BCMA …
treatment of hematologic malignancies, including multiple myeloma (MM). Two BCMA …
CAR T-cell therapy for multiple myeloma: A clinical practice-oriented review.
NL Sadek, BA Costa, K Nath… - Clinical Pharmacology …, 2023 - europepmc.org
The emergence of chimeric antigen receptor (CAR) T-cell therapy has revolutionized the
treatment of hematologic malignancies, including multiple myeloma (MM). Two B-cell …
treatment of hematologic malignancies, including multiple myeloma (MM). Two B-cell …
CAR T-cell therapy for multiple myeloma: A clinical practice-oriented review
NL Sadek, BA Costa, K Nath… - Clinical pharmacology … - pubmed.ncbi.nlm.nih.gov
The emergence of chimeric antigen receptor (CAR) T-cell therapy has revolutionized the
treatment of hematologic malignancies, including multiple myeloma (MM). Two B-cell …
treatment of hematologic malignancies, including multiple myeloma (MM). Two B-cell …
[PDF][PDF] CAR T-Cell Therapy for Multiple Myeloma: A Clinical Practice-Oriented Review
NL Sadek, BA Costa, K Nath… - CLINICAL …, 2023 - researchgate.net
The emergence of chimeric antigen receptor (CAR) T-cell therapy has revolutionized the
treatment of hematologic malignancies, including multiple myeloma (MM). Two BCMA …
treatment of hematologic malignancies, including multiple myeloma (MM). Two BCMA …